Cargando…

Bioimaging Nucleic-Acid Aptamers with Different Specificities in Human Glioblastoma Tissues Highlights Tumoral Heterogeneity

Nucleic-acid aptamers are of strong interest for diagnosis and therapy. Compared with antibodies, they are smaller, stable upon variations in temperature, easy to modify, and have higher tissue-penetration abilities. However, they have been little described as detection probes in histology studies o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cruz Da Silva, Elisabete, Foppolo, Sophie, Lhermitte, Benoît, Ingremeau, Marina, Justiniano, Hélène, Klein, Lorraine, Chenard, Marie-Pierre, Vauchelles, Romain, Abdallah, Basma, Lehmann, Maxime, Etienne-Selloum, Nelly, Dontenwill, Monique, Choulier, Laurence
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609998/ https://www.ncbi.nlm.nih.gov/pubmed/36297416 http://dx.doi.org/10.3390/pharmaceutics14101980

Ejemplares similares

Selection of Nucleic Acid Aptamers Targeting Tumor Cell-Surface Protein Biomarkers
por: Mercier, Marie-Cécile, et al.
Publicado: (2017)

RNA Aptamers Targeting Integrin α5β1 as Probes for Cyto- and Histofluorescence in Glioblastoma
por: Fechter, Pierre, et al.
Publicado: (2019)

A Systematic Review of Glioblastoma-Targeted Therapies in Phases II, III, IV Clinical Trials
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2021)

Blocking EREG/GPX4 Sensitizes Head and Neck Cancer to Cetuximab through Ferroptosis Induction
por: Jehl, Aude, et al.
Publicado: (2023)

Role of Integrins in Resistance to Therapies Targeting Growth Factor Receptors in Cancer
por: Cruz da Silva, Elisabete, et al.
Publicado: (2019)

Expression/activation of α5β1 integrin is linked to the β-catenin signaling pathway to drive migration in glioma cells
por: Renner, Guillaume, et al.
Publicado: (2016)

DIPG-31. HIF-1A AND HIF-2A COMBINATORIAL TARGETING OR HOW TO REVERSE THEIR BALANCED ONCOGENIC IMPACT
por: Fuchs, Quentin, et al.
Publicado: (2023)

Temozolomide-Acquired Resistance Is Associated with Modulation of the Integrin Repertoire in Glioblastoma, Impact of α5β1 Integrin
por: Sani, Saidu, et al.
Publicado: (2022)

A DNA Repair and Cell Cycle Gene Expression Signature in Pediatric High-Grade Gliomas: Prognostic and Therapeutic Value
por: Entz-Werlé, Natacha, et al.
Publicado: (2021)

Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma
por: Etienne-Selloum, Nelly, et al.
Publicado: (2021)

Cav1/EREG/YAP Axis in the Treatment Resistance of Cav1-Expressing Head and Neck Squamous Cell Carcinoma
por: Burgy, Mickaël, et al.
Publicado: (2021)

Tumor-Suppressive and Immunomodulating Activity of miR-30a-3p and miR-30e-3p in HNSCC Cells and Tumoroids
por: Conrad, Ombline, et al.
Publicado: (2023)

HGG-34. A DNA DAMAGE REPAIR SIGNATURE IN PRIMARY AND RECURRENT PEDIATRIC HIGH-GRADE GLIOMAS: PROGNOSTIC AND THERAPEUTIC VALUE
por: Entz-Werle, Natacha, et al.
Publicado: (2021)

DIPG-30. HIF2 OVEREXPRESSION DICTATES AGGRESSIVENESS ADDITIONALLY TO TP53 MUTATIONS IN H3.3K27M PEDIATRIC HIGH-GRADE GLIOMAS THROUGH RAS-MAPK AND WNT/BCATENIN PATHWAYS
por: Fuchs, Quentin, et al.
Publicado: (2023)

Nucleic Acid Aptamers in Nanotechnology
por: Sinitsyna, Valentina V., et al.
Publicado: (2022)

Aptamer‐mediated synthesis of multifunctional nano‐hydroxyapatite for active tumour bioimaging and treatment
por: Zhang, Wenqing, et al.
Publicado: (2021)

The Amplified DNA Logic Gates Based on Aptamer–Receptor Recognition for Cell Detection and Bioimaging
por: Wang, Yajing, et al.
Publicado: (2023)

Selective Targeting to Glioma with Nucleic Acid Aptamers
por: Aptekar, Shraddha, et al.
Publicado: (2015)

Aptamers, the Nucleic Acid Antibodies, in Cancer Therapy
por: Fu, Zhaoying, et al.
Publicado: (2020)

Recent Progress and Opportunities for Nucleic Acid Aptamers
por: Byun, Jonghoe
Publicado: (2021)

Caveolin-1-negative head and neck squamous cell carcinoma primary tumors display increased epithelial to mesenchymal transition and prometastatic properties
por: Jung, Alain C., et al.
Publicado: (2015)

ZrMOF nanoparticles as quenchers to conjugate DNA aptamers for target-induced bioimaging and photodynamic therapy
por: Liu, Yuan, et al.
Publicado: (2018)

Chemical Modifications of Nucleic Acid Aptamers for Therapeutic Purposes
por: Ni, Shuaijian, et al.
Publicado: (2017)

Nucleic acid aptamer-based methods for diagnosis of infections
por: Park, Ki Soo
Publicado: (2018)

Therapeutic applications of nucleic acid aptamers in microbial infections
por: Afrasiabi, Shima, et al.
Publicado: (2020)

Exploiting the Nucleic Acid Nature of Aptamers for Signal Amplification
por: Jauset-Rubio, Miriam, et al.
Publicado: (2022)

Role of Endocytosis Proteins in Gefitinib-Mediated EGFR Internalisation in Glioma Cells
por: Cruz Da Silva, Elisabete, et al.
Publicado: (2021)

HGG-39. Integrative analyses of BRAFp.v600e mutated gliomas: from epigenetic to metabolic characteristics
por: Lhermitte, Benoit, et al.
Publicado: (2022)

β1 Integrins as Therapeutic Targets to Disrupt Hallmarks of Cancer
por: Blandin, Anne-Florence, et al.
Publicado: (2015)

A Controllable Aptamer-Based Self-Assembled DNA Dendrimer for High Affinity Targeting, Bioimaging and Drug Delivery
por: Zhang, Huimin, et al.
Publicado: (2015)

Nucleic Acid Aptamers as Potential Therapeutic and Diagnostic Agents for Lymphoma
por: Shum, Ka-To, et al.
Publicado: (2013)

Recent Progress in Nucleic Acid Aptamer-Based Biosensors and Bioassays
por: Mok, Wendy, et al.
Publicado: (2008)

Nucleic Acid Aptamers: An Emerging Tool for Biotechnology and Biomedical Sensing
por: Ku, Ti-Hsuan, et al.
Publicado: (2015)

Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
por: Santosh, Baby, et al.
Publicado: (2014)

Molecular dynamics study of the recognition of ATP by nucleic acid aptamers
por: Xie, Ya-chen, et al.
Publicado: (2020)

Splitting aptamers and nucleic acid enzymes for the development of advanced biosensors
por: Debiais, Mégane, et al.
Publicado: (2020)

Advanced quantification for single-cell adhesion by variable-angle TIRF nanoscopy
por: El Arawi, Dalia, et al.
Publicado: (2021)

A Highlight of Recent Advances in Aptamer Technology and Its Application
por: Sun, Hongguang, et al.
Publicado: (2015)

Molecular Heterogeneity in BRAF-Mutant Gliomas: Diagnostic, Prognostic, and Therapeutic Implications
por: Lhermitte, Benoit, et al.
Publicado: (2023)

Nucleic acid aptamers for targeting of shRNA-based cancer therapeutics
por: Vorhies, John S, et al.
Publicado: (2007)

Cannot write session to /tmp/vufind_sessions/sess_dc5em3mcnh0bp7hgm8aks4qmve